<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="447">
  <stage>Registered</stage>
  <submitdate>7/09/2005</submitdate>
  <approvaldate>9/09/2005</approvaldate>
  <actrnumber>ACTRN12605000354684</actrnumber>
  <trial_identification>
    <studytitle>Clinical Application of exhaled Nitric Oxide measurements in PrimarY care</studytitle>
    <scientifictitle>Assessing the utility of exhaled nitric oxide measurements in the diagnosis of asthma and the monitoring of inhaled steroid treatment in primary care</scientifictitle>
    <utrn />
    <trialacronym>CANOPY</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Asthma</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Asthma</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Algorithms based on previous research are used to guide diagnostic and treatment decision making in patients with asthma in primary care.  Patients will be followed up at 3 month intervals for one year using the algorithm to guide clinical decisions making regarding inhaled steroid dose.</interventions>
    <comparator />
    <control>Uncontrolled</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Change in asthma control questionnaire scores.</outcome>
      <timepoint>At baseline and at the end of one year.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Change in asthma quality of life questionnaire scores.</outcome>
      <timepoint>At baseline and at the end of one year.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Change in overall dose of inhaled corticosteroid prescribed.</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Total use of oral steroids.</outcome>
      <timepoint>The total steroid doses will be compared for the year prior to study entry and the year of participation in the study.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Diagnostic arm: Inclusion - patients over 12yrs old with wheeze, cough or dyspnoea for &gt;6weeks duration. Treatment arm: Inclusion - asthmatic patients &gt;12yrs old.</inclusivecriteria>
    <inclusiveminage>12</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Exclusion for both arms current or recent ex-smokers (&lt;6months).</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>5/01/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>200</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Otago</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of Otago</fundingname>
      <fundingaddress />
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Mornington Health Centre Dunedin</sponsorname>
      <sponsoraddress />
      <sponsorcountry>New Zealand</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Professor D Robin Taylor</name>
      <address>Otago Respiratory Research Group
Dunedin School of Medicine
University of Otago
PO Box 913
Dunedin</address>
      <phone>+64 3 4740999 (Ext. 8785)</phone>
      <fax />
      <email>robin.taylor@stonebow.otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Richard Hewitt</name>
      <address>Otago Respiratory Research Group
Dunedin School of Medicine
University of Otago
PO Box 913
Dunedin</address>
      <phone>+64 3 4740999 (Ext. 8785)</phone>
      <fax />
      <email>richard.hewitt@stonebow.otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>